Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about gene therapy

Recent news which mentions gene therapy

< Previous 1 2 3 Next >
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
Tickers AGTC
Tags General Health Care AGTC
From Benzinga
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Market News Benzinga Penny Stocks
From Benzinga
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
Tickers PFE
Tags FDA Benzinga PFE
From Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
Tickers OCGN
Tags Small Cap Biotech gene therapy
From Benzinga
Creative Biolabs Announces Sponsorship and Exhibition at PEGS Boston 2022
Tags antibody Biotechnology gene therapy
From PRUnderground
Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
Tickers FOLD
Tags Market News Benzinga Trading Ideas
From Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Tickers BLUE NTLA
Tags Market News NTLA Penny Stocks
From Benzinga
Why Bluebird Bio Shares Are Tumbling Today
Tickers BLUE
Tags Health Care gene therapy Biotech
From Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
Tickers ARYD FOLD
Tags Health Care FOLD gene therapy
From Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
Tickers TAK TKPHF
Tags News gene therapy Contracts
From Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
Tickers BMRN
Tags FDA Benzinga Market News
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags RGNX News Briefs
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags Fabry disease AVRO General
From Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
Tickers SGMO
Tags News Briefs General
From Benzinga
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
Tickers SIOX
Tags Briefs SIOX News
From Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
Tickers TSHA
Tags Benzinga Market News Health Care
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags TSHA News Briefs
From Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Tickers FBIO MBIO
Tags Benzinga FDA Penny Stocks
From Benzinga
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
Tickers BLUE
Tags Market News Benzinga FDA
From Benzinga
Sarepta Abandons Lysogene-Partnered Pivotal-Stage Gene Therapy Candidate
Tickers SRPT
Tags Market News Benzinga Biotech
From Benzinga
Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
Tickers BLUE
Tags Health Care Biotech Small Cap
From Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
Tickers BMRN
Tags General Health Care Biotech
From Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
Tickers PFE
Tags Movers Briefs News
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags General Health Care Briefs
From Benzinga
Why Are Bluebird Bio Shares Trading Lower Today?
Tickers BLUE
Tags Health Care Small Cap Biotech
From Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
Tickers BLUE
Tags gene therapy Biotech Small Cap
From Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
Tickers QURE
Tags QURE General Movers
From Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Tickers BLUE
Tags BLUE General Movers
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
Tickers BLUE
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
Tickers SELB
Tags General why it's moving News
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.